Get the Stockscreener App
112.98
1.53%
2.78
Icon Plc stock is traded at $112.98, with a volume of 77,023.
It is up +1.53% in the last 24 hours and down -23.04% over the past month.
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
See More
Previous Close:
$110.20
Open:
$108.43
24h Volume:
77,023
Relative Volume:
0.04
Market Cap:
$8.58B
Revenue:
$8.10B
Net Income/Loss:
$599.48M
P/E Ratio:
15.27
EPS:
7.3969
Net Cash Flow:
$971.54M
1W Performance:
+5.43%
1M Performance:
-23.04%
6M Performance:
-36.02%
1Y Performance:
-40.00%
1-Day Range:
$108.43
$112.91
1-Week Range:
$103.74
$112.40
52-Week Range:
$66.57
$211.00
Icon Plc Stock (ICLR) Company Profile
Compare ICLR vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
112.31 | 8.41B | 8.10B | 599.48M | 971.54M | 7.3969 |
|
TMO
Thermo Fisher Scientific Inc
|
509.70 | 192.62B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
203.16 | 144.77B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
633.19 | 51.65B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
119.20 | 34.09B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
318.29 | 31.30B | 3.17B | 642.63M | 516.49M | 10.77 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-18-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-17-26 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Feb-12-26 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-12-26 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jan-08-26 | Downgrade | Truist | Buy → Hold |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Sep-09-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-03-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Aug-21-25 | Downgrade | Citigroup | Buy → Neutral |
| Jul-24-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-29-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-21-25 | Downgrade | Goldman | Buy → Neutral |
| Jan-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Oct-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Neutral |
| Sep-18-24 | Initiated | Leerink Partners | Outperform |
| Jun-06-24 | Initiated | Goldman | Buy |
| Dec-15-23 | Initiated | Truist | Buy |
| Sep-13-23 | Initiated | TD Cowen | Outperform |
| Jan-17-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-13-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Nov-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-07-22 | Initiated | UBS | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-12-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-27-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-21 | Initiated | Citigroup | Neutral |
| Apr-13-21 | Resumed | BofA Securities | Neutral |
| Apr-01-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-08-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-03-21 | Initiated | Barclays | Equal Weight |
| Mar-01-21 | Upgrade | UBS | Neutral → Buy |
| Feb-26-21 | Upgrade | Truist | Hold → Buy |
| Jul-24-20 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-20-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-02-20 | Initiated | Deutsche Bank | Hold |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Sep-23-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jul-26-19 | Upgrade | UBS | Sell → Neutral |
| Jan-25-19 | Upgrade | Mizuho | Neutral → Buy |
| Oct-26-18 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-09-18 | Initiated | UBS | Sell |
| Apr-03-18 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-15-18 | Reiterated | Mizuho | Neutral |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
| Oct-27-17 | Reiterated | Barclays | Equal Weight |
| Sep-11-17 | Initiated | BofA/Merrill | Buy |
| Jul-31-17 | Upgrade | SunTrust | Hold → Buy |
| Jul-27-17 | Reiterated | Mizuho | Neutral |
| Jun-29-17 | Upgrade | Jefferies | Hold → Buy |
View All
Icon Plc Stock (ICLR) Latest News
ICLR (NASDAQ: ICLR) files Form 144 for 566 vested restricted shares on 03/03/2026 - Stock Titan
ICON plc Under Investigation for Possible Securities Fraud - Intellectia AI
Finemark National Bank & Trust Has $458,000 Stake in Icon Plc $ICLR - MarketBeat
ICLR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ICON plcOrdinary Shares (NQ: ICLR - The Chronicle-Journal
ICON Plc (ICLR) Stock Analysis: Unpacking The 37% Upside Potential - DirectorsTalk Interviews
JPMorgan Chase & Co. Decreases Holdings in Icon Plc $ICLR - MarketBeat
ICON plc Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
Icon Plc (NASDAQ:ICLR) Short Interest Down 29.2% in February - MarketBeat
Jefferies Bullish on ICON (ICLR) Despite Share Price Decline - Finviz
ICON plc Opens with a 5.16% Gain After Recent Decline of 44.25% - Markets Mojo
Icon plc under the microscope over ‘misstated’ clinical trial revenue - The Times
Keystone Investors PTE Ltd. Takes Position in Icon Plc $ICLR - MarketBeat
ICON plc (ICLR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Icon (NASDAQ:ICLR) Downgraded by Zacks Research to "Strong Sell" - MarketBeat
Icon Plc $ICLR Shares Sold by Artisan Partners Limited Partnership - MarketBeat
Westfield Capital Management Co. LP Has $69.36 Million Stake in Icon Plc $ICLR - MarketBeat
Ademi LLP Investigates Claims of Securities Fraud against ICON plc - ChartMill
Thornburg Investment Management Inc. Sells 17,435 Shares of Icon Plc $ICLR - MarketBeat
Internship for Life Science Students at ICON Careers | Opportunity for Life Science Students - BioTecNika
Here's How Much You Would Have Made Owning Icon Stock In The Last 20 Years - Sahm
Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICON plcICLR - marketscreener.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICON plcICLR - ChartMill
Here is Why ICON Public Limited Company (ICLR) Offers an Impressive Upside - Finviz
ICON plc earnings delayed to April as accounting investigation unfolds By Investing.com - Investing.com Canada
Clinical Research Provider Icon Stock Crashes On Accounting Probe - AOL.com
ICON plc (ICLR) Stock Analysis: Exploring the 58% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
ICLR: Jefferies Upgrades Icon with Lowered Price Target | ICLR S - GuruFocus
Aberdeen Group plc Lowers Position in Icon Plc $ICLR - MarketBeat
ICON PLC (ICON) soars 16% as analyst issues 'hold', $93 PT despite accounting concerns - MSN
Jefferies upgrades ICON stock on valuation despite lower target By Investing.com - Investing.com UK
Jefferies upgrades ICON stock on valuation despite lower target - Investing.com
2026-02-22 | ICON plc (ICLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:ICLR | Press Release - Stockhouse
Icon faces big test after share price tumble - The Irish Times
ICLR SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations - GlobeNewswire Inc.
Investigation into ICON Public Limited Company for Securities Law Violations - Intellectia AI
Bronstein, Gewirtz & Grossman, LLC Encourages ICON plc (ICLR) Stockholders to Inquire about Securities Investigation - Stockhouse
73,467 Shares in Icon Plc $ICLR Purchased by Muhlenkamp & Co. Inc. - MarketBeat
TD Cowen upgrades ICON stock on valuation after accounting probe By Investing.com - Investing.com India
ICON INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Icon plc: Accounting Probe Sell-Off Creates Compelling Value Despite Modest EPS Impact - TipRanks
2026-02-18 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ICON plc (ICLR) and Encourages Investors to Learn More About the Investigation | NDAQ:ICLR | Press Release - Stockhouse
ICON plc Faces Investigation After Internal Probe Reveals Multi-Year Revenue Overstatement - GuruFocus
TD Cowen upgrades ICON stock on valuation after accounting probe - Investing.com
TD Cowen Upgrades Icon PLC(ICLR.US) to Buy Rating, Cuts Target Price to $120 - 富途牛牛
Icon Plc Stock (ICLR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.77%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):